Insider Buying Week 4-1-22 Beaten Down Biotech Enough is Enough

  Curious how well insiders are doing with their buys? Scroll the significant buys of the last year.   We are fully in the nether world of earnings blackout.  It’s difficult anytime to discern the mood of corporate America but the period thirty days prior to and one day after quarterly earnings release are deliberately void of any communication about the health of a public company’s business. It’s the blackout period. Not as sexy as a black hole but nonetheless filled with mischieve and potential danger. I’ve asked my friend Dan Taylor of Wharton Forensics Lab and Frank from SECForm4.com … Read more

Insider Buying week 01-07-22 and What a Week it Was

  Curious how well insiders are doing with their buys? Scroll the significant buys of the last year. This was certainly an interesting week.  The Nasdaq Generals got a dressing down from their leader, the general market investing public. They said loud and clear that if you insiders are selling droves of your stock, you better give us a better explanation why we shouldn’t be too.  Since dividends are rare and the only benefit of holding these highflyers is that their actual free cash flow-making abilities might one day catch up with their inflated stock price, investors seemed to all … Read more

Insider Buying week 6-18-21

For trade, details click on this link to the trades  All the talking heads made fools of themselves last week.  Powel said the economy was doing great; the Dow plummeted, its worst week since October of last year. The market marched in lockstep, giving up on the cyclical recovery trade, hammering banks, energy, material sectors, and lifted the neglected technology growth sector. The Fed said they got it that inflation was running hotter than they thought, and they might tweak interest rates higher a wee bit sooner.  Instead of interest rates going up, long-term interest rates plummeted, and the yield … Read more